Your browser doesn't support javascript.
loading
Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.
Roth, David; Nelson, David R; Bruchfeld, Annette; Liapakis, AnnMarie; Silva, Marcelo; Monsour, Howard; Martin, Paul; Pol, Stanislas; Londoño, Maria-Carlota; Hassanein, Tarek; Zamor, Philippe J; Zuckerman, Eli; Wan, Shuyan; Jackson, Beth; Nguyen, Bach-Yen; Robertson, Michael; Barr, Eliav; Wahl, Janice; Greaves, Wayne.
Affiliation
  • Roth D; Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: d.roth@med.miami.edu.
  • Nelson DR; Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA.
  • Bruchfeld A; Department of Renal Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
  • Liapakis A; Yale University Digestive Disease, Yale New Haven Hospital Transplant Center, New Haven, CT, USA.
  • Silva M; Hospital Universitario Austral, Pilar, Argentina.
  • Monsour H; Hepatology & Transplant Medicine, Houston Methodist Hospital, Houston, TX, USA.
  • Martin P; Division of Hepatology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Pol S; Unité d'Hépatologie, Hôpital Cochin; Université Paris Descartes; and UMS20, Institut Pasteur; Paris, France.
  • Londoño MC; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
  • Hassanein T; Southern California Research Center, Coronado, CA, USA.
  • Zamor PJ; Division of Hepatology, Carolinas Medical Center, Charlotte, NC, USA.
  • Zuckerman E; Liver Unit, Carmel Medical Center Technion Faculty of Medicine, Haifa, Israel.
  • Wan S; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Jackson B; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Nguyen BY; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Robertson M; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Barr E; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Wahl J; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Greaves W; Merck & Co, Inc, Kenilworth, NJ, USA.
Lancet ; 386(10003): 1537-45, 2015 Oct 17.
Article in En | MEDLINE | ID: mdl-26456905
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protease Inhibitors / Quinoxalines / Benzofurans / Hepatitis C, Chronic / Renal Insufficiency, Chronic / Imidazoles Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2015 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protease Inhibitors / Quinoxalines / Benzofurans / Hepatitis C, Chronic / Renal Insufficiency, Chronic / Imidazoles Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Lancet Year: 2015 Type: Article